Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Sunlight and a hike may reset your internal clock better than office lighting

NCT ID NCT05513547

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how daylight and physical activity influence the body's internal clock and sleep. Fifty-one healthy adults aged 18-35 were exposed to different lighting conditions (office light, natural daylight, or daylight with blue-light-blocking glasses) and either rested or hiked for 4 hours. Researchers measured shifts in melatonin onset and sleep quality to understand how these factors affect circadian rhythms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

51 people

The number who actually took part.

Started

Apr 2023

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age: 18-35 years * Body Mass Index: 18.5-24.9 (i.e., normal weight according to World Health Organization (WHO) criteria) * Moderate cardiorespiratory fitness levels, moderate level of endurance training according to the category "moderate physical activity" (category 2) of the International Physical Activity Questionnaire (IPAQ) short form * Informed consent as documented by signature of the participant Exclusion Criteria: * Self-reported pregnancy * Investigator's family members, employees, or other dependent persons * Chronic or debilitating medical (including psychiatric) conditions; normal state of health will be established on the basis of questionnaires and the examination by the physician in charge. Illnesses that would be a reason for exclusion are: * Sleep disorders: Narcolepsy, sleep apnea (apnea index \> 10), periodic limb movements (PLM index \> 15), insomnia (polygraphically recorded sleep efficiency \< 70% or Pittsburgh Sleep Quality Index (PSQI) index \> 5), hypersomnia * Chronobiological disorders: hypernychthemeral sleep-wake cycle, delayed or advanced sleep phase syndrome * Psychiatric disorders * Somatic diseases: cardiovascular, respiratory, gastrointestinal, haemopoietic, visual and immune system diseases, neurological disorders, infectious diseases, allergies (e.g., skin allergies, acute hay fever), thrombocytopenia or other dysfunctions of blood platelets * Drug use: volunteers must not consume any drugs (including nicotine and alcohol) for the entire duration of the study with no history of drug or alcohol dependency. This will be ensured by the use of a urine multi-drug screen at every experimental visit. * Medication that could affect outcome parameters * Shift work \< 3 months prior to study intake * Transmeridian travel (\> 2 time zones) \< 1 month prior to study intake * Extreme chronotype (Munich Chronotype Questionnaire \[MCTQ\] \<2 or \>7) * Extremely long/short sleep duration (subjective sleep duration on workdays outside 6-10h according to the MCTQ) * Abnormal colour vision, vision disorders (other than e.g., mild myopia corrected with contact lenses) * Inability to understand and/or follow procedures * Non-adherence to the circadian stabilization protocol during the five days prior to and between the experimental visits (deviation of \>30min form scheduled times more than twice or on the day of the study visit)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Circadian system are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre for Chronobiology, Psychiatric Hospital of the University of Basel

    Basel, 4002, Switzerland